Cargando…

Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic

SIMPLE SUMMARY: Telemedicine became widespread during the COVID-19 pandemic, but little is known about its persistence in routine cancer care after the pandemic’s peak. This study examined telemedicine use for breast and prostate cancer patients at a New York City cancer center before, during, and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimonas, Susan, Lipitz-Snyderman, Allison, Spiegelhoff, Zoe, Chakraborty, Nirjhar, Seier, Kenneth, White, Charlie, Kuperman, Gilad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605853/
https://www.ncbi.nlm.nih.gov/pubmed/37894328
http://dx.doi.org/10.3390/cancers15204961
_version_ 1785127177963962368
author Chimonas, Susan
Lipitz-Snyderman, Allison
Spiegelhoff, Zoe
Chakraborty, Nirjhar
Seier, Kenneth
White, Charlie
Kuperman, Gilad
author_facet Chimonas, Susan
Lipitz-Snyderman, Allison
Spiegelhoff, Zoe
Chakraborty, Nirjhar
Seier, Kenneth
White, Charlie
Kuperman, Gilad
author_sort Chimonas, Susan
collection PubMed
description SIMPLE SUMMARY: Telemedicine became widespread during the COVID-19 pandemic, but little is known about its persistence in routine cancer care after the pandemic’s peak. This study examined telemedicine use for breast and prostate cancer patients at a New York City cancer center before, during, and after the pandemic’s peak. Telemedicine usage increased from 2% before the pandemic to 50% during the peak and then decreased to 30% after the peak. Both during and after the peak, psychiatry, social work, and nutrition conducted almost all visits remotely, while surgery and nursing maintained low telemedicine usage. Most departments continued to use telemedicine at or above peak levels, except for medicine, neurology, and survivorship. Anesthesiology and neurology used telemedicine more for follow-ups, while nursing used it more for new visits. These findings highlight specific contexts where patients and providers choose telemedicine even when other options are available. However, more research is needed to assess telemedicine’s suitability for and impact on cancer care. ABSTRACT: While COVID-19 catalyzed a shift to telemedicine, little is known about the persistence of remote cancer care in non-emergent times. We assessed telemedicine use at a high-volume academic cancer center in New York City and analyzed breast and prostate cancer visits pre-COVID-19, peak COVID-19, and post-peak. Descriptive statistics assessed visit mode (in person, telemedicine) and type (new, follow-up, other) by department/specialty, with Fisher’s exact tests comparing peak/post-peak differences. The study included 602,233 visits, with telemedicine comprising 2% of visits pre-COVID-19, 50% peak COVID-19, and 30% post-peak. Notable variations emerged by department/specialty and visit type. Post-peak, most departments/specialties continued using telemedicine near or above peak levels, except medicine, neurology, and survivorship, where remote care fell. In psychiatry, social work, and nutrition, nearly all visits were conducted remotely during and after peak COVID-19, while surgery and nursing maintained low telemedicine usage. Post-peak, anesthesiology and neurology used telemedicine seldom for new visits but often for follow-ups, while nursing showed the opposite pattern. These trends suggest department- and visit-specific contexts where providers and patients choose telemedicine in non-emergent conditions. More research is needed to explore these findings and evaluate telemedicine’s appropriateness and impact across the care continuum.
format Online
Article
Text
id pubmed-10605853
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106058532023-10-28 Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic Chimonas, Susan Lipitz-Snyderman, Allison Spiegelhoff, Zoe Chakraborty, Nirjhar Seier, Kenneth White, Charlie Kuperman, Gilad Cancers (Basel) Article SIMPLE SUMMARY: Telemedicine became widespread during the COVID-19 pandemic, but little is known about its persistence in routine cancer care after the pandemic’s peak. This study examined telemedicine use for breast and prostate cancer patients at a New York City cancer center before, during, and after the pandemic’s peak. Telemedicine usage increased from 2% before the pandemic to 50% during the peak and then decreased to 30% after the peak. Both during and after the peak, psychiatry, social work, and nutrition conducted almost all visits remotely, while surgery and nursing maintained low telemedicine usage. Most departments continued to use telemedicine at or above peak levels, except for medicine, neurology, and survivorship. Anesthesiology and neurology used telemedicine more for follow-ups, while nursing used it more for new visits. These findings highlight specific contexts where patients and providers choose telemedicine even when other options are available. However, more research is needed to assess telemedicine’s suitability for and impact on cancer care. ABSTRACT: While COVID-19 catalyzed a shift to telemedicine, little is known about the persistence of remote cancer care in non-emergent times. We assessed telemedicine use at a high-volume academic cancer center in New York City and analyzed breast and prostate cancer visits pre-COVID-19, peak COVID-19, and post-peak. Descriptive statistics assessed visit mode (in person, telemedicine) and type (new, follow-up, other) by department/specialty, with Fisher’s exact tests comparing peak/post-peak differences. The study included 602,233 visits, with telemedicine comprising 2% of visits pre-COVID-19, 50% peak COVID-19, and 30% post-peak. Notable variations emerged by department/specialty and visit type. Post-peak, most departments/specialties continued using telemedicine near or above peak levels, except medicine, neurology, and survivorship, where remote care fell. In psychiatry, social work, and nutrition, nearly all visits were conducted remotely during and after peak COVID-19, while surgery and nursing maintained low telemedicine usage. Post-peak, anesthesiology and neurology used telemedicine seldom for new visits but often for follow-ups, while nursing showed the opposite pattern. These trends suggest department- and visit-specific contexts where providers and patients choose telemedicine in non-emergent conditions. More research is needed to explore these findings and evaluate telemedicine’s appropriateness and impact across the care continuum. MDPI 2023-10-12 /pmc/articles/PMC10605853/ /pubmed/37894328 http://dx.doi.org/10.3390/cancers15204961 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chimonas, Susan
Lipitz-Snyderman, Allison
Spiegelhoff, Zoe
Chakraborty, Nirjhar
Seier, Kenneth
White, Charlie
Kuperman, Gilad
Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic
title Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic
title_full Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic
title_fullStr Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic
title_full_unstemmed Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic
title_short Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic
title_sort persistence of telemedicine usage for breast and prostate cancer after the peak of the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605853/
https://www.ncbi.nlm.nih.gov/pubmed/37894328
http://dx.doi.org/10.3390/cancers15204961
work_keys_str_mv AT chimonassusan persistenceoftelemedicineusageforbreastandprostatecancerafterthepeakofthecovid19pandemic
AT lipitzsnydermanallison persistenceoftelemedicineusageforbreastandprostatecancerafterthepeakofthecovid19pandemic
AT spiegelhoffzoe persistenceoftelemedicineusageforbreastandprostatecancerafterthepeakofthecovid19pandemic
AT chakrabortynirjhar persistenceoftelemedicineusageforbreastandprostatecancerafterthepeakofthecovid19pandemic
AT seierkenneth persistenceoftelemedicineusageforbreastandprostatecancerafterthepeakofthecovid19pandemic
AT whitecharlie persistenceoftelemedicineusageforbreastandprostatecancerafterthepeakofthecovid19pandemic
AT kupermangilad persistenceoftelemedicineusageforbreastandprostatecancerafterthepeakofthecovid19pandemic